8. ハンチントン病 Huntington disease Clinical trials / Disease details
臨床試験数 : 229 / 薬物数 : 193 - (DrugBank : 60) / 標的遺伝子数 : 84 - 標的パスウェイ数 : 158
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04826692 (ClinicalTrials.gov) | September 2021 | 15/9/2020 | TEsting METformin Against Cognitive Decline in HD | Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Metformin, an Activator of AMPK, on Cognitive Measures of Progression in Huntington's Disease Patients | Huntington Disease | Drug: Metformin;Drug: Placebo | Instituto de Investigacion Sanitaria La Fe | NULL | Not yet recruiting | 21 Years | 65 Years | All | 60 | Phase 3 | NULL |